Unknown OBSERVATIONAL NCT01612559

Safety Study of Kudiezi (a Chinese Medicine Injection) Used in Hospitals in China (RSCMI-Ⅱ)

A Registry Study on Safety Surveillance of Kudiezi (a Chinese Medicine Injection) Used in China

Sponsor: China Academy of Chinese Medical Sciences

Conditions Angina Pectoris Coronary Heart Disease

Updated 7 times since 2017 Last updated: Jun 3, 2012 Started: Jan 31, 2012 Primary completion: Dec 31, 2014 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01612559, this observational or N/A phase trial focuses on Angina Pectoris and Coronary Heart Disease and remains ongoing. Sponsored by China Academy of Chinese Medical Sciences, it has been updated 7 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
May 2019 — Jan 2021 [monthly]

Unknown Status
Jun 2018 — May 2019 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Academy of Chinese Medical Sciences
Dongfang Hospital Beijing University of Chinese Medicine

Data source: China Academy of Chinese Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.